Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023

BUY
$32.09 - $37.51 $930,257 - $1.09 Million
28,989 Added 67.12%
72,182 $2.39 Million
Q2 2023

Jul 19, 2023

BUY
$36.12 - $41.79 $155,749 - $180,198
4,312 Added 11.09%
43,193 $1.58 Million
Q1 2023

May 03, 2023

BUY
$39.39 - $51.28 $227,398 - $296,039
5,773 Added 17.44%
38,881 $1.59 Million
Q4 2022

Feb 06, 2023

BUY
$41.75 - $54.5 $117,108 - $152,872
2,805 Added 9.26%
33,108 $1.7 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $166,200 - $202,889
3,798 Added 14.33%
30,303 $1.33 Million
Q2 2022

Aug 09, 2022

BUY
$46.53 - $55.17 $212,223 - $251,630
4,561 Added 20.78%
26,505 $1.39 Million
Q1 2022

May 10, 2022

SELL
$45.75 - $56.69 $492,407 - $610,154
-10,763 Reduced 32.91%
21,944 $1.14 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $231,350 - $342,938
5,599 Added 20.65%
32,707 $1.39 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $100,637 - $129,276
2,564 Added 10.45%
27,108 $1.17 Million
Q2 2021

Aug 10, 2021

BUY
$35.91 - $40.68 $60,256 - $68,261
1,678 Added 7.34%
24,544 $960,000
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $54,555 - $61,527
1,629 Added 7.67%
22,866 $830,000
Q4 2020

Feb 08, 2021

SELL
$33.47 - $42.56 $17,772 - $22,599
-531 Reduced 2.44%
21,237 $782,000
Q3 2020

Nov 10, 2020

BUY
$31.75 - $37.25 $6,254 - $7,338
197 Added 0.91%
21,768 $799,000
Q2 2020

Aug 10, 2020

BUY
$30.12 - $36.54 $18,975 - $23,020
630 Added 3.01%
21,571 $703,000
Q1 2020

Apr 23, 2020

BUY
$27.03 - $38.62 $48,140 - $68,782
1,781 Added 9.3%
20,941 $682,000
Q4 2019

Feb 12, 2020

BUY
$32.92 - $37.36 $630,747 - $715,817
19,160 New
19,160 $751,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Marks Group Wealth Management, Inc Portfolio

Follow Marks Group Wealth Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marks Group Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Marks Group Wealth Management, Inc with notifications on news.